Objective: Nitric oxide deficiency may contribute to microvascular dysfunction in sepsis. Current physiologic paradigms contend that nitrite and/or S-nitrosohemoglobin mediate intravascular delivery of nitric oxide. These nitric oxide metabolites are purportedly consumed during hemoglobin deoxygenation, producing nitric oxide and coupling intravascular nitric oxide delivery with metabolic demand. Systemic nitrite and S-nitrosohemoglobin consumption can be assessed by comparing their concentrations in arterial vs. venous blood. We hypothesized that arterial vs. venous differences in nitrite and S-nitrosohemoglobin are diminished in sepsis and associated with mortality.
T he purported roles of nitric oxide (NO) in sepsis are contradictory: excessive production causing hypotension (1) , and reduced production impairs microvascular blood flow (2) . Excessive NO production in human sepsis is suggested by elevated concentrations of plasma nitrate plus nitrite (3) (4) (5) (6) . However, recent metabolic isotope studies indicate reduced NO production in septic patients (7, 8) . Furthermore, inhibiting NO production increases the risk of mortality in septic patients (9) . NO appears to have endocrine activity, with physiologic effects occurring distant from the NO source (10) . This presumably occurs by formation of circulating NO metabolites that are consumed as hemoglobin deoxygenates, releasing NO bioactivity and matching blood flow with metabolic need. S-nitrosohemoglobin (SNOHb) (11) and nitrite (12) are postulated mediators of this effect. In vivo, this paradigm is supported by studies showing higher arterial vs. venous concentrations of nitrite and SNOHb (10 -14) , suggesting consumption of the metabolite (and coincident NO release) in the systemic vasculature. This is analogous to measuring the arteriovenous (A-V) oxygen content difference, with larger differences suggesting higher systemic oxygen consumption. Although there is growing agreement that such intravascular NO delivery occurs, controversy surrounds the identity of responsible metabolite(s) (15) .
Reports of nitrite and SNOHb concentrations in septic humans are limited (16 -18) . There are no reports of paired arterial and venous measurements in sepsis. We hypothesized that systemic consumption of these NO metabolites is impaired in sepsis and associated with mortality. To test this hypothesis, we measured arterial and venous levels of NO metabolites in patients with severe sepsis or septic shock and a control group without acute illness. We reasoned that A-V NO metabolite differences should be present in healthy subjects, but not in sepsis patients. We further reasoned that A-V differences should be disrupted to a greater extent in sepsis nonsurvivors compared to survivors.
MATERIALS AND METHODS

Study Design
Consecutive patients meeting diagnostic criteria for severe sepsis or septic shock (19) in the medical or surgical intensive care unit (ICU) of the University of Rochester Medical Center were eligible. Control subjects without acute illness were recruited by age and gender strata approximating the sepsis cohort. Exclusion criteria are listed in Table 1 . The primary outcome measures were presence of sepsis and hospital mortality. Written informed consent was obtained from subjects or surrogate decision-makers. This study was approved by the University of Rochester Research Subjects Review Board.
Measurement of NO Metabolites
Arterial and venous blood samples were obtained within 48 hrs of severe sepsis/septic shock diagnosis or during an outpatient visit to the Clinical Research Center in control subjects. NO metabolites were measured using tri-iodide (I 3 Ϫ )based reductive chemiluminescence (20) (21) (22) (see description of methods in Supplemental Digital Content 1, http://links.lww.com/CCM/A109). The assays yielded measurements of plasma, red blood cell (RBC) and whole blood (WB) nitrite, plasma nitrate, SNOHb, RBC XNO (RBC XNO signifies primarily iron-nitrosyl hemoglobin [Fe-NOHb] but may also include RBC nitrosamines) (23, 24) , and the combination of plasma nitrosothiols, metal nitrosyl compounds, and nitrosamines.
Statistical Analysis
NO metabolite distributions were rightskewed. Normal distributions were approximated by square-root transformations of plasma nitrate and log (base 10) transformations of the other NO metabolites. The data were transformed accordingly before statistical analysis. Paired Student's t tests were used to compare arterial and venous NO metabolite concentrations. Unpaired Student's t tests with unequal variance were used to compare metabolites between cases and controls and between survivors and nonsurvivors. Chi-square testing was used for comparison of categorical variables. Two-way analysis of variance (ANOVA) was used to assess differences in NO metabolite concentrations between groups while controlling for potential confounding variables (see statistical methods in Supplemental Digital Content 1, http://links.lww.com/CCM/A109). Results are summarized as means with 95% confidence interval after back-transformation to the 
RESULTS
Research Subjects
From February 2006 to July 2008, 597 ICU patients were screened and 87 met enrollment criteria ( Fig. 1 ). Samples were collected 27 Ϯ 12 hrs (mean Ϯ SD) after diagnosis of severe sepsis or septic shock. Fifty-two nonseptic control subjects were recruited. Subject characteristics are shown in Table 2 . Technical problems precluded measurement of WB nitrite in three sepsis patients and SNOHb in four subjects (one control subject, three sepsis patients).
Sepsis Patients vs. Control Subjects
In control subjects, arterial nitrite was significantly higher than venous nitrite in plasma, WB, and RBC, suggesting nitrite consumption in the systemic circulation, whereas arterial SNOHb was lower than venous SNOHb, suggesting SNOHb production ( Table 3 , Fig. 2 ) (25) . The A-V difference in RBC XNO was not statistically significant ( Table 3) .
Comparing sepsis patients to control subjects, there were no differences in ar-terial or venous plasma nitrite, and the A-V plasma nitrite difference was significant in both groups ( Table 3 , Fig. 2 ). In contrast, venous WB and RBC nitrite were significantly higher in septic patients than in controls, but arterial WB and RBC nitrite levels were similar. This blunted the WB and RBC nitrite A-V (arterial Ͼ venous) nitrite differences in septic patients, suggesting impaired intra-erythrocytic nitrite utilization. Opposite results were observed for venous SNOHb. Compared to controls, sepsis patients had significantly lower venous SNOHb, but arterial levels were similar. This narrowed the A-V (venous Ͼ arterial) SNOHb difference in septic patients ( Table  3 , Fig. 2 ), suggesting impaired SNOHb pro- 
Organ dysfunction, n f .07 Values are number of subjects (percentage), unless otherwise specified; b p for comparison of sepsis patients to control subjects; c p for comparison of sepsis survivors to sepsis nonsurvivors; d mean Ϯ SD; e median (interquartile range); f organ dysfunctions as defined previously (44) with slight modification, including: cardiovascular (hypotension ͓systolic blood pressure Ͻ90 mmHg or mean arterial pressure Ͻ60 mm Hg͔, vasopressor requirement, or clinical evidence of hypoperfusion); acid-base (metabolic acidosis and plasma lactate concentration Ͼ2 mmol/L); renal (urine output Ͻ0.5 mL/kg/hr despite fluid resuscitation); neurologic (altered mental status without other causes); respiratory (Pao 2 :Fio 2 ratio Ͻ250, or Ͻ200 if lungs are only dysfunctional organ); hematologic (platelet count Ͻ80,000 or Ͼ50% decrease from baseline); g shock, hypotension or vasopressor dependence that persisted for 3 hrs despite fluid challenge.
duction. There were no differences in arterial or venous RBC XNO between controls and sepsis patients. Arterial and venous nitrate were higher in sepsis patients compared to controls ( Table 3 ). The sum concentration of plasma nitrosothiols, metal nitrosyls, and nitrosamines was Ͻ12 nM in arterial and venous blood of sepsis and control subjects (data not shown).
Two-way ANOVA showed that renal function confounded the apparent relationship between both arterial and venous nitrate and sepsis (creatinineadjusted p values for associations between arterial or venous nitrate and sepsis Ͼ0.60; analysis summarized in Supplemental Table 1, see Supplemental Digital Content 5, http://links.lww.com/CCM/A113). In contrast, the association between venous WB nitrite and sepsis persisted after adjustment for possible confounding variables (adjusted p value for association between WB nitrite and sepsis ϭ .014). Two-way ANOVA indicated that the association between venous SNOHb and sepsis was weakened after controlling for history of hypertension (adjusted p value ϭ .194). To ensure that the diminished A-V SNOHb difference in sepsis patients was not confounded by differences in hypertension history between sepsis patients and control subjects, SNOHb A-V differences were examined in sepsis patients and controls, stratified by hypertension history. Arterial SNOHb was less than venous SNOHb in controls without hypertension (n ϭ 40; arterial, 42 
Hospital Survivors vs. Nonsurvivors
Twenty-eight patients (32%) with severe sepsis or septic shock died in the hospital ( Table 2 ). The A-V plasma nitrite difference was significant in survivors but not in nonsurvivors ( Fig. 3) , which is a consequence of higher venous plasma nitrite in nonsurvivors (Table 4) , suggesting nonsurvivors have more generalized impairment of nitrite consumption in both plasma and RBC nitrite storage pools. The A-V difference in RBC XNO was significant in survivors but not nonsurvivors (Table 4) .
Age was a potential confounder of the relationship between higher venous plasma nitrite and hospital mortality (analysis summarized in Supplemental trast, arterial and venous plasma nitrite levels were similar in nonsurvivors age 62 yrs or younger (n ϭ 8; arterial, 67 [14 -321] 
DISCUSSION
Our results demonstrate that septic patients have elevated venous WB and RBC nitrite concentrations and reduced venous SNOHb concentrations, blunting the A-V nitrite and SNOHb concentration differences observed in nonseptic control subjects. In addition, sepsis nonsurvivors are distinguished from survivors by an isolated increase in venous plasma nitrite that narrows the plasma nitrite A-V difference. These findings have implications for understanding the role of intravascular NO delivery in the pathophysiology of human sepsis.
Sepsis-Associated Disruption of Nitrite-Mediated NO Delivery?
In vitro, nitrite and RBC together vasodilate vascular tissue preparations, re-lease NO gas, and produce FeNOHb in an oxygen-dependent manner that is optimized at the hemoglobin P 50 (oxygen tension corresponding to 50% hemoglobin oxygen saturation) (22, 26) . This reaction also generates dinitrogen trioxide (N 2 O 3 ), a potent nitrosating agent that produces nitrosothiols and SNOHb and decomposes to NO and nitrogen dioxide outside the RBC (25) .
Our results support this model of NO delivery in humans. In control subjects, we find significant A-V plasma, WB, and RBC nitrite concentration differences (arterial Ͼ venous), confirming results from previous studies and suggesting systemic nitrite consumption (10, 12, 13) . Furthermore, we demonstrate significant A-V SNOHb concentration differences (venous Ͼ arterial), suggesting production of SNOHb in the systemic circulation. Previous studies of A-V SNOHb differences report conflicting results (14, 22, 27) . Our large community-derived control group may have facilitated detection of significant A-V (venous Ͼ arterial) SNOHb concentration gradients under basal conditions. These findings underscore the necessity of studying a large, healthy control group to establish expected NO metabolite concentrations in those with age and gender distributions similar to the septic cohort.
Venous WB and RBC nitrite levels were higher and venous SNOHb levels were lower in septic patients, narrowing A-V differences observed in control subjects. Additionally, sepsis nonsurvivors had higher venous plasma nitrite concentration than survivors, without significant A-V difference. These findings suggest impaired nitrite consumption in sepsis that is associated with mortality when involving both plasma and RBC nitrite pools.
The deoxyhemoglobin-mediated nitrite reductase pathway also predicts higher FeNOHb concentrations in vein vs. artery (28) , a difference that should be obscured in sepsis patients, particularly nonsurvivors. The A-V RBC XNO difference (venous Ͼ arterial) was statistically significant in sepsis survivors but not in sepsis nonsurvivors (Table 4 ), consistent with impaired nitrite reduction according to this model.
We hypothesize that these results reflect dysregulated intra-erythrocytic deoxyhemoglobin-mediated nitrite reduction ( Fig. 4) , a process postulated to occur in an intra-erythrocytic nitrite "metabolon" comprising the RBC membrane, membrane-associated proteins, deoxyhemoglobin, and nitrite (28) . We speculate that endotoxin-induced changes in RBC membrane and cytoskeletal proteins (29, 30) may affect the ability of RBCs to facilitate nitrite-mediated NO activity.
Lower availability of deoxyhemoglobin could also impair nitrite biotransformation, because the nitrite-reducing capacity of hemoglobin is optimized when the oxygen saturation is approximately 50% (26) . Septic shock is characterized by abnormally high mixed venous hemoglobin oxygen saturation (31) , which could impair hemoglobin nitrite reductase activity. Sepsis-associated mitochondrial dysfunction or oxidative stress could also disrupt nitrite reductase activity in vascular and extravascular tissues (32, 33) , independent of RBCs and hemoglobin.
It is possible that higher venous nitrite concentrations and blunted A-V nitrite differences could result from increased systemic nitrite production rather than impaired nitrite utilization. Ceruloplasmin oxidizes NO to nitrite (34) , so elevated systemic NO production and ceruloplasmin could explain the nitrite results (35) . However, this mechanism does not explain lower venous SNOHb levels or blunted A-V SNOHb dif- ferences. Furthermore, increased systemic NO production and oxidation to nitrite would be expected to increase both venous and arterial nitrite concentrations, because the half-life of nitrite in blood is approximately 42 mins (36) . Instead, we found that control subjects, sepsis patients, sepsis survivors, and sepsis nonsurvivors all had similar arterial plasma, WB, and RBC nitrite levels. Impaired nitrite reduction to NO is a more likely explanation for our results, because it accounts for all of these findings.
Another possibility is that elevated nitrate levels cause higher venous nitrite levels. Recent reports indicate that nitrate reductases convert nitrate to nitrite in vivo (37) . However, nitrate reduction to nitrite does not explain the absent SNOHb A-V gradient in sepsis or the similar arterial levels of nitrite in all study groups. Impaired intra-erythrocytic ni-trite reduction to NO accounts for all of these findings.
Comparison With Previous Studies
Arterial WB nitrite measurements using I 3 Ϫ chemiluminescence were recently reported in 30 ICU patients, including 12 patients with sepsis (17) . Consistent with our results, no significant differences in (22, 25) . N 2 O 3 S-nitrosates Hb forming S-nitrosohemoglobin (SNOHb), then exits the RBC through a membrane-associated protein complex, where it decomposes to NO (and nitrogen dioxide, not shown), augmenting microvascular blood flow (28) . Plasma nitrite (PNO 2 Ϫ ) enters the RBC to replenish RBCNO 2 Ϫ (42, 43) . This metabolic pathway is reflected by different NO metabolite concentrations changes in the draining vein. The net result is arteriovenous (A-V) differences in NO metabolite concentrations, with higher plasma and RBC nitrite (PNO 2 Ϫ and RBCNO 2 Ϫ ) in artery vs. vein, but lower SNOHb and FeNOHb in artery vs. vein (10, 12, 13, 22) . B, Sepsis. RBC nitrite metabolism is impaired either because of sepsis-associated derangements of the RBC membrane-associated proteins involved in nitrite reduction and NO export (gray color of membrane protein) or because of lower concentration of deoxyHb (smaller font) (30, 31) . The production of SNOHb and FeNOHb decline (dashed arrows and smaller font), and there is diminished RBC NO release (dashed arrows and smaller font), impairing microvascular blood flow (smaller arrow). The defects in membrane-associated proteins and RBCNO 2 Ϫ metabolism are not yet severe enough to affect PNO 2 Ϫ uptake. The net result is diminished A-V differences in all metabolites except PNO 2 Ϫ . C, Lethal sepsis. The membrane-associated protein and metabolic defects are more severe, eliminating NO export (black color of membrane protein complex) and critically reducing blood flow (smaller arrow). The defects are now severe enough to impair PNO 2 Ϫ uptake by the RBC (gray color of membrane channel, larger PNO 2 Ϫ font). The net result is diminished A-V differences for all NO metabolites shown. arterial WB nitrite between septic and nonseptic patients or between those with and without renal dysfunction were found.
Two reports describe markedly elevated SNOHb concentrations in six (16) and 12 (18) septic subjects, but artery-tovein differences were not reported. Discrepancies between the results of Liu et al (18) and our SNOHb measurements are likely attributable to methodologic differences (21) . The I 3
Ϫ chemiluminescence method used herein has been validated repeatedly (24, 27, 38, 39) and is considered a preferred method for these analyses (40) . Differences in sample size, patient characteristics, or the timing of blood sampling relative to sepsis diagnosis may account for discrepancies between our results and those of Doctor et al (16) . Elevated SNOHb concentrations have also been reported in animal models of sepsis (23, 41) . However, species variation in NO metabolism makes these findings difficult to apply to humans (24) .
Unadjusted arterial and venous nitrate concentrations were higher in sepsis patients compared to control subjects, but these differences were lost after adjustment for renal dysfunction. Villalpando et al (7) also found that elevated plasma nitrate plus nitrite concentrations in septic patients were tightly correlated with renal function, and they further demonstrated that the fractional synthesis rate of plasma nitrate plus nitrite is reduced in septic vs. control subjects. Together, these data cast doubt on the commonly held view that human sepsis is characterized by excessive and detrimental NO production (1, 3, 6) .
Study Limitations
The limitations of this study included practical constraints on the site and timing of NO metabolite measurements. Venous blood samples were obtained from peripheral veins in control subjects, but usually from central venous catheters in septic patients to minimize discomfort and risk. We are unaware of any published data indicating that venous NO metabolite concentrations differ in peripheral vs. central venous blood. Because venous plasma nitrite concentrations were nearly identical in control subjects (peripheral vein sampling) vs. septic patients (primarily central vein sampling; Fig. 2, Table 3 ), it is unlikely that there is a systematic difference in the nitrite concentrations of central vs. pe-ripheral blood. Furthermore, venous samples (without matching arterial samples) were obtained in 45 of the sepsis patients just before hospital discharge, either peripherally (n ϭ 27) or centrally (n ϭ 18), depending on available venous access. There were no significant differences between peripherally and centrally obtained concentrations of nitrite or SNOHb (see additional results in Supplemental Digital Content 1, http://links.lww.com/CCM/A109).
Samples were obtained approximately 27 hrs after severe sepsis or septic shock diagnosis. Earlier measurements may have allowed determination of the onset of dysregulated NO metabolism. However, we found no differences in nitrite or SNOHb when analyzed by tertiles of the time interval between sepsis diagnosis and sample collection, suggesting the abnormalities are established early (Supplemental Table 3 , see Supplemental Digital Content 7, http://links.lww.com/CCM/A115).
This study required inclusion of a relatively healthy, nonhospitalized control group to establish baseline NO metabolite values in people of similar age as our sepsis patients. We cannot exclude the possibility that the results observed in our sepsis cohort also apply to other critically ill populations. If so, then these results have even greater applicability. This possibility requires further study.
CONCLUSIONS
A-V nitrite and SNOHb differences are diminished in patients with severe sepsis and septic shock, and the absence of a significant A-V plasma nitrite difference is associated with mortality. The blunted A-V nitrite and SNOHb differences may signify a detrimental metabolic blockade of nitrite consumption that impairs microvascular blood flow. Further studies are required to determine relationships between nitrite consumption, RBC characteristics, and microvascular blood flow in sepsis. Such information could advance efforts to therapeutically harness NO activity and improve microvascular function in sepsis.
